This is not the most recent version of the article. View current version (5 OCT 2011)

Intervention Protocol

Epidermal growth factor receptor blockers for the treatment of ovarian cancer

  1. Krishnayan Haldar1,*,
  2. Kezia Gaitskell2,
  3. Andrew Bryant3,
  4. Heather O Dickinson3,
  5. Shibani Nicum4,
  6. Sean Kehoe1,
  7. Jo Morrison5

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 7 OCT 2009

DOI: 10.1002/14651858.CD007927.pub2


How to Cite

Haldar K, Gaitskell K, Bryant A, Dickinson HO, Nicum S, Kehoe S, Morrison J. Epidermal growth factor receptor blockers for the treatment of ovarian cancer (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD007927. DOI: 10.1002/14651858.CD007927.pub2.

Author Information

  1. 1

    Oxford Cancer and Haematology Centre, Oxford Gynaecological Oncology Centre, Level 0, Oxford, UK

  2. 2

    UCL Medical School, North Central Thames Foundation School, London, UK

  3. 3

    Newcastle University, Institute of Health and Society, Newcastle upon Tyne, UK

  4. 4

    Oxford Cancer and Haematology Centre, NHS Department of Oncology, Level 2, Oxford, UK

  5. 5

    University of Oxford, Nuffield Department of Obstetrics and Gynaecology, Oxford, UK

*Krishnayan Haldar, Oxford Gynaecological Oncology Centre, Level 0, Oxford Cancer and Haematology Centre, Churchill Hospital, Old Road, Oxford, OX3 7LJ, UK. krishnayan_haldar@yahoo.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

This is not the most recent version of the article. View current version (05 OCT 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effectiveness and harmful effects of interventions, which target the epidermal growth factor receptor, in the treatment of ovarian cancer.